Serenex Report issue

For profit Phase 1
Founded: Durham NC United States (2001)
Status: Acquired by Pfizer (2008)

Organization Overview

First Clinical Trial
2007
NCT00506805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Serenex, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

snx-5422 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hematologic Neoplasms (Phase 1)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1